Company intelligence / Profile preview

Lantibio

Chapel Hill, North Carolina, United Statesir.intelliatx.com ↗

Ownership: Private
Development stage: Commercial

Overview

Lantibio was a private pharmaceutical company focused on developing therapies for ocular diseases and serious respiratory conditions. Its lead programs included Moli1901/lancovutide for cystic fibrosis and Vismed® sodium hyaluronate eye drops for dry eye syndrome. The company reported positive Phase II results in cystic fibrosis with Moli1901 and advanced Vismed® into US Phase III trials under an agreement with Alcon. There are no recent updates indicating ongoing clinical development or commercialization.

Therapeutic areas: OphthalmologyPulmonology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

TRB Chemedica (licensing/manufacturing partner for ophthalmology products)Alcon Laboratories Inc. (US marketing/manufacturing partner for dry eye product)AOP Orphan Pharmaceuticals AG (European licensing/commercialization partner for Moli1901/cystic fibrosis program)

Beyond the preview

Go deeper on Lantibio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lantibio.

Explore the full profile